Breaking
Friday, June 19, 2026

Drug Approvals News

🇪🇺 EMA

EMA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 120 articles

Critical impact NewsJun 15, 2026

EMA board backs Ebola response, flags 2025 annual report at June meeting

EMA · Ebola · 5 min

Dr. Elena Rossi
High impact NewsJun 14, 2026

FDA approves capivasertib plus abiraterone and prednisone in PTEN-deficient mHSPC

FDA · prostate cancer · 6 min

Dr. Elena Rossi
High impact NewsJun 13, 2026

Truqap gains US approval in PTEN-deficient metastatic prostate cancer

FDA · prostate cancer · 6 min

Dr. Elena Rossi
High impact NewsJun 12, 2026

Duty of care at oncology conferences spotlights planetary health research

Oncology · 4 min

Dr. Elena Rossi
Critical impact NewsJun 12, 2026

Synthetic real-world data reshapes oncology trial decision-making

Oncology · 4 min

Dr. Elena Rossi
High impact NewsJun 12, 2026

EMA approved 104 human medicines in 2025: what changed

EMA · osteoporosis · 6 min

Dr. Elena Rossi
High impact NewsJun 12, 2026

EMA Post Authorisation Guidance Faces Evidence Gaps After 10 Years

EMA · 4 min

Dr. Elena Rossi
High impact NewsJun 11, 2026

EMA approves TX01 PIP, unlocking the PUMA pathway for Theranexus and Exeltis

EMA · 5 min

Dr. Elena Rossi
Critical impact NewsJun 11, 2026

CHMP backs nerandomilast for IPF and PPF in EU

European Medicines Agency · idiopathic pulmonary fibrosis · 6 min

Dr. Elena Rossi
High impact NewsJun 8, 2026

Eye drugs list: Sodium hyaluronate, tafluprost, tobramycin uses

FDA · dry eyes · 5 min

Dr. Elena Rossi
High impact NewsJun 7, 2026

EMEA 2026 Life Sciences Report: Key Market Shifts for Pharma BD and Investors

4 min

Dr. Elena Rossi
High impact NewsJun 6, 2026

Maersk Europe Market Update June 2026: Key Changes for Pharma Supply Chains

4 min

Dr. Elena Rossi